Evidence map›Paper›PMID 34222098›Full record

ReviewJournal of diabetes and metabolic disorders2021

The effects of dietary selenium supplementation on inflammatory markers among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.

Shirin Djalalinia, Motahareh Hasani, Hamid Asayesh, Hanieh-Sadat Ejtahed, Hanieh Malmir, Amir Kasaeian, Maryam Zarei, Fereshteh Baygi, Hadith Rastad, Armita Mahdavi Gorabi and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Shirin DjalaliniaDevelopment of Research & Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.
Motahareh HasaniSchool of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Hamid AsayeshDepartment of Medical Emergencies, Qom University of Medical Sciences, Qom, Iran.
Hanieh-Sadat EjtahedObesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hanieh MalmirObesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amir KasaeianHematology-Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Maryam ZareiDepartment of Nutrition and Dietetics Faculty of Medicine and Health Sciences , University Putra Malaysia , Selangor Serdang, Malaysia.
Fereshteh BaygiCentre of Maritime Health and Society, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark.
Hadith RastadCardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Armita Mahdavi GorabiSocial Determinants of Health Research Center Alborz, University of Medical Sciences , Karaj, Iran.
Mostafa QorbaniNon-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.ORCID 0000-0001-9465-7588
Jahrom University of Medical Sciences · IRTehran University of Medical Sciences · IRIran University of Medical Sciences · IRMinistry of Health and Medical Education · IRQom University of Medical Science and Health Services · IRUniversiti Putra Malaysia · MYUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSelenium (Se) is a trace element having significant effects on human metabolism. Recent studies suggest that Se supplementation have a pivotal effect on the inflammatory markers. Therefore, the aim of this study was to assess the effect of Se supplementation on plasma inflammatory markers including C-reactive protein (CRP) and high-sensitivity C-reactive protein (hs-CRP) and nitric oxide (NO) as a stress oxidative index, among patients with metabolic diseases.

methodsTo assess the effects of Se on the inflammatory markers, following the PRISMA-P guidelines, we systematically searched ISI/WOS, PubMed/MEDLINE, and Scopus for studies that assessed the effect of Se supplementation on the inflammatory markers. Data extraction was performed by two independent investigators. Using the random effects or fixed-effects model depending on the results of heterogeneity tests was used to estimate the pooled standardized mean difference (SMD). Heterogeneity between studies was assessed using Cochran's Q test and I

resultsThe initial search revealed 3,320 papers. After screening process and considering inclusion criteria, 7 publications were eligible for inclusion in the meta-analysis. The meta-analysis results showed that Se supplementation did not significantly affect CRP and hs-CRP concentrations (mean difference (MD) = -0.15; 95% CI: -0.55- 0.23; P = 0.43). Subgroup analysis of CRP type showed that Se supplementation significantly decreased hs-CRP level (pooled SMD = -0.44; 95% CI: -0.67-0.21). Moreover, no significant change was observed in NO level by continuing to take Se supplementation, (pooled SMD: 0.003, 95%CI: -0.26, 0.26).

conclusionsThis study revealed that Se supplementation would have desirable effects on cardio-metabolic indicators through affecting the levels of inflammatory markers. Given the importance of concerns, more attention should be given to more prospective studies with longer follow-up.

Indexed as

InflammationInflammatory markersSeleniumSupplementationSystematic review

Identifiers

PMID34222098
PMCPMC8212246
OpenAlexW3167614020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.